More PolyNovo Limited news
PolyNovo LimitedASX: PNV

Taiwan FDA Approval for PolyNovo

Oct 27, 2020 at 10:32 PM EDT · Issued by PolyNovo Limited

Filed with ASX · Oct 27, 2020 at 10:32 PM EDT · 1 page · English

On 6ix: 6ix.com/news/taiwan-fda-approval-for-polynovo

Watch PolyNovo's latest call↗PolyNovo (ASX:PNV) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of PolyNovo (ASX:PNV) Q4 2026 Earnings Call↗

PolyNovo Limited on 6ix

Story so far

  • BTM CE mark approvalDec 13, 2019
  • Singapore Regulatory ApprovalAug 8, 2019
  • Malaysia Regulatory ApprovalJan 18, 2019

Earlier from PolyNovo

  • Appointment of distributor for FinlandSep 22, 2020
  • FY20 Results PresentationAug 26, 2020
  • Appendix 4E and FY20 Annual ReportAug 26, 2020
  • BARDA funding for Pivotal TrialJul 14, 2020
  • Trading UpdateJul 9, 2020

Later from PolyNovo

  • USA FDA approves Pivotal Trial IDENov 12, 2020
  • Chairman, Managing Director & SVP of Sales US - AGM addressNov 13, 2020
  • PolyNovo enters Belgium, Netherlands, Luxemburg & SwedenNov 18, 2020
  • Trading Update - H1 FY21Jan 11, 2021
  • Response to ASX QueryJan 17, 2021
All PolyNovo news releases↗

Follow PolyNovo into a list and get an email when it puts out news.

Follow PolyNovo
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer